STOCK TITAN

BML Investment Partners discloses 7.8% stake in enGene (ENGN) on 05/08/2026

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

enGene Holdings Inc. ownership disclosure: BML Investment Partners, L.P. reports beneficial ownership of 5,225,000 common shares, representing 7.8% of the class as shown on 05/08/2026. The filing states shared voting and dispositive power over these shares through BML Capital Management, LLC and Braden M. Leonard.

Positive

  • None.

Negative

  • None.

Insights

Large passive stake disclosed by an investment partnership; holdings reported as shared power.

BML Investment Partners, L.P. reports beneficial ownership of 5,225,000 common shares (CUSIP 29286M105), equal to 7.8% of outstanding shares as of 05/08/2026. The filing attributes voting and dispositive authority to shared-control entities.

Future disclosures or amendments would show any changes; the filing includes a standard disclaimer that the reporting persons do not form a statutory group under Rule 13d-5(b)(1). Cash-flow treatment and intended disposition strategies are not described in the excerpt.

CUSIP 29286M105 enGene Common Shares identifier
Beneficial ownership 5,225,000 shares Amount beneficially owned as reported in the Schedule 13G
Percent of class 7.8% Percent of common shares beneficially owned as of 05/08/2026
Shared voting power 5,225,000 shares Shared power to vote reported in Item 4
Shared dispositive power 5,225,000 shares Shared power to dispose reported in Item 4
Schedule 13G regulatory
"Item 1. (a) Name of issuer: enGene Holdings Inc."
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficial ownership financial
"Item 4. (a) Amount beneficially owned: 5225000"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared dispositive power governance
"(iv) Shared power to dispose or to direct the disposition of: 5225000"
CUSIP regulatory
"(e) | CUSIP Number(s): 29286M105"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does BML Investment Partners hold in enGene (ENGN)?

BML Investment Partners, L.P. reports beneficial ownership of 5,225,000 common shares, equal to 7.8% of the class as of 05/08/2026. The filing shows shared voting and dispositive power over those shares.

Who controls the reported enGene shares for BML Investment Partners?

The filing names BML Capital Management, LLC as the general partner and Braden M. Leonard as managing member, who is deemed an indirect owner of the 5,225,000 shares reported on 05/08/2026.

Does the Schedule 13G state whether BML is part of a group?

The filing expressly disclaims that the reporting persons constitute a statutory group under Rule 13d-5(b)(1). It therefore treats the position as held by the named entities rather than a coordinated group.

What voting and dispositive powers are reported for the 5,225,000 shares?

The Schedule 13G reports 0 sole voting power and 5,225,000 shared voting power, and similarly 0 sole dispositive power with 5,225,000 shared dispositive power, per the filing.

What identifier and filing date appear in the disclosure?

The disclosure references CUSIP 29286M105 for enGene Common Shares and the ownership snapshot is dated 05/08/2026, with a signature dated 05/13/2026 by the reporting party.





29286M105

(CUSIP Number)
05/08/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



BML Investment Partners, L.P.
Signature:Braden M Leonard
Name/Title:BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Date:05/13/2026

Comments accompanying signature: BML Investment Partners, L.P. is a Delaware limited partnership whose sole general partner is BML Capital Management, LLC. The managing member of BML Capital Management, LLC is Braden M. Leonard. As a result, Braden M. Leonard is deemed to be the indirect owner of the shares held directly by BML Investment Partners, L.P. Despite such shared beneficial ownership, the reporting persons disclaim that they constitute a statutory group within the meaning of Rule 13d-5(b)(1) of the Exchange Act.